Physical activity in patients with idiopathic pulmonary fibrosis

Respirology

Volumn 20, Issue 4, 2015, Pages 640-646

  Nakayama, Masayuki ^a   Bando, Masashi ^a   Araki, Koji ^a   Sekine, Toshie ^a   Kurosaki, Fumio ^a   Sawata, Tetsuro ^a   Nakazawa, Shoko ^a   Mato, Naoko ^a   Yamasawa, Hideaki ^a   Sugiyama, Yukihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

6 min walk test; accelerometer; idiopathic pulmonary fibrosis; Krebs von den Lungen 6; physical activity

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; KREBS VON DEN LUNGEN 6; PROTEIN; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ACCELEROMETER; ADULT; AGED; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; ENERGY EXPENDITURE; EXERCISE INTENSITY; FEMALE; FIBROSING ALVEOLITIS; FORCED VITAL CAPACITY; HEART RATE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TOTAL LUNG CAPACITY; WALKING; EXERCISE TEST; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY;

AGED; EXERCISE TEST; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MOTOR ACTIVITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84927724676     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12500     Document Type: Article

References (20)

1. Watz H, Waschki B, Meyer T, Magnussen H,. Physical activity in patients with COPD. Eur. Respir. J. 2009; 33: 262-272.
2. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, Magnussen H,. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331-342.
3. Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D, Galera R, Villasante C,. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012; 142: 338-346.
4. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
5. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319-338.
6. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005; 26: 720-735.
7. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26: 511-522.
8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-117.
9. Kumahara H, Schutz Y, Ayabe M, Yoshioka M, Yoshitake Y, Shindo M, Ishii K, Tanaka H,. The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry. Br. J. Nutr. 2004; 91: 235-243.
10. Sewell L, Singh SJ, Williams JE, Morgan MD,. Seasonal variations affect physical activity and pulmonary rehabilitation outcomes. J Cardiopulm Rehabil Prev 2010; 30: 329-333.
11. Sugino A, Minakata Y, Kanda M, Akamatsu K, Koarai A, Hirano T, Sugiura H, Matsunaga K, Ichinose M,. Validation of a compact motion sensor for the measurement of physical activity in patients with chronic obstructive pulmonary disease. Respiration 2012; 83: 300-307.
12. Van Remoortel H, Hornikx M, Langer D, Burtin C, Everaerts S, Verhamme P, Boonen S, Gosselink R, Decramer M, Troosters T, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2014; 189: 30-38.
13. Wallaert B, Monge E, Le Rouzic O, Wémeau-Stervinou L, Salleron J, Grosbois JM,. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144: 1652-1658.
14. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S,. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir. Med. 2009; 103: 117-123.
15. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M,. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989; 96: 68-73.
16. Yokoyama A, Kohno N, Kondo K, Ueda S, Hirasawa Y, Watanabe K, Takada Y, Hiwada K,. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia. Respirology 1998; 3: 199-202.
17. Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, Bando M, Sugiyama Y, Totani Y, Ishizaki T, et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164-168.
18. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE Jr, Bradford WZ, Schwartz DA, et al.; Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488-493.
19. Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, Wilson F, Rabinovich R, Vogiatzis I, Hopkinson NS, et al.; PROactive consortium. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS ONE 2012; 7: e39198. doi: 10.1371/journal.pone.0039198; [Epub 2012 Jun 20].
20. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S, Burtin C, Regueiro EM, Vogiatzis I, Hopkinson NS, et al.; PROactive Consortium. Validity of physical activity monitors during daily life in patients with COPD. Eur. Respir. J. 2013; 42: 1205-1215.